Weekly News Round-up – 3/7/20
Big news this week, with the U.S. administration buying up remdesivir’s stock for the next three months, ensuring no other country will receive any. In other news, Pfizer and BioNTech’s own covid drug has shown promising results in early trials,...
4 years agoWeekly News Round-up – 3/7/20
Big news this week, with the U.S. administration buying up remdesivir’s stock for the next three months, ensuring no other country will receive any. In other news, Pfizer and BioNTech’s own covid drug has shown promising results in early trials,...
4 years ago
Weekly News Round-up – 19/6/20
This week, pharma begins looking beyond the imminent struggle against Covid-19’s initial challenges to the further horizon, and the dreaded second wave. Vaccine demand in a number of countries is rising in preparation of easing lockdowns, while Gilead’s remdesivir starts...
5 years agoWeekly News Round-up – 19/6/20
This week, pharma begins looking beyond the imminent struggle against Covid-19’s initial challenges to the further horizon, and the dreaded second wave. Vaccine demand in a number of countries is rising in preparation of easing lockdowns, while Gilead’s remdesivir starts...
5 years ago
Weekly News Round-up – 5/6/20
The race for a COVID-19 vaccine continues, with AstraZeneca set to double potential capacity after a new deal struck with two companies supported by Bill and Melinda Gates. In other news, the WHO is set to restart trials for hydroxychloroquine,...
5 years agoWeekly News Round-up – 5/6/20
The race for a COVID-19 vaccine continues, with AstraZeneca set to double potential capacity after a new deal struck with two companies supported by Bill and Melinda Gates. In other news, the WHO is set to restart trials for hydroxychloroquine,...
5 years ago
Weekly News Round-up – 22/5/20
Big news this week, with AstraZeneca potentially ready to produce a Covid-19 vaccine by September this year, and Moderna receiving good news about its early-stage human trials for the same thing. In other news, the Trump administration’s new manufacturing partner...
5 years agoWeekly News Round-up – 22/5/20
Big news this week, with AstraZeneca potentially ready to produce a Covid-19 vaccine by September this year, and Moderna receiving good news about its early-stage human trials for the same thing. In other news, the Trump administration’s new manufacturing partner...
5 years ago
Weekly News Round-up – 15/5/20
In the news this week, remdesivir is authorised for emergency use in COVID-19. The drug has still not been proven to increase survival rates, but it will be vital to reduce patient recovery times. In other news, Takeda announces surprise...
5 years agoWeekly News Round-up – 15/5/20
In the news this week, remdesivir is authorised for emergency use in COVID-19. The drug has still not been proven to increase survival rates, but it will be vital to reduce patient recovery times. In other news, Takeda announces surprise...
5 years ago
The Rise of Independent Clinical Trial Sites
When looking for the right trial site for their study, clinical sponsors need a number of specific measures and conditions that will ensure greatest value for them. Enrolling requirements must be met, but more importantly the most rigorous safety and quality...
5 years agoThe Rise of Independent Clinical Trial Sites
When looking for the right trial site for their study, clinical sponsors need a number of specific measures and conditions that will ensure greatest value for them. Enrolling requirements must be met, but more importantly the most rigorous safety and quality...
5 years ago
Weekly News Round-up – 1/5/20
This week, Covid-19 vaccines see some advancement, with remdesivir showing strong signs of success as Pfizer prepare to put their own candidate through U.S. trials starting from next week. In other news, ‘natural killer’ cell therapies show strong potential efficacy...
5 years agoWeekly News Round-up – 1/5/20
This week, Covid-19 vaccines see some advancement, with remdesivir showing strong signs of success as Pfizer prepare to put their own candidate through U.S. trials starting from next week. In other news, ‘natural killer’ cell therapies show strong potential efficacy...
5 years ago
Data Quality in Virtual Clinical Trials
Arguably no other area in pharmaceutical science has suffered under Covid-19 like clinical trials have. The damage done by Covid-19 - to patient engagement, to supply chains and to hospitals - has shaken the industry. But with such a crisis...
5 years agoData Quality in Virtual Clinical Trials
Arguably no other area in pharmaceutical science has suffered under Covid-19 like clinical trials have. The damage done by Covid-19 - to patient engagement, to supply chains and to hospitals - has shaken the industry. But with such a crisis...
5 years ago
Weekly News Round-up – 24/4/20
This week saw a slight slowdown of the big news we’ve come to expect over the last few months, with only minor changes to the ever-shifting coronavirus front. That said, two of the Covid-19 treatment forerunners saw big announcements as...
5 years agoWeekly News Round-up – 24/4/20
This week saw a slight slowdown of the big news we’ve come to expect over the last few months, with only minor changes to the ever-shifting coronavirus front. That said, two of the Covid-19 treatment forerunners saw big announcements as...
5 years ago
Weekly News Round-up – 17/4/20
This week, a glimpse of non-Covid normalcy is provided by news that a Tagrisso lung cancer study was unblinded early after ‘overwhelming accuracy’, potentially expanding the drug’s usage further. In other (Covid-related) news, GSK and Sanofi are set to collaborate...
5 years agoWeekly News Round-up – 17/4/20
This week, a glimpse of non-Covid normalcy is provided by news that a Tagrisso lung cancer study was unblinded early after ‘overwhelming accuracy’, potentially expanding the drug’s usage further. In other (Covid-related) news, GSK and Sanofi are set to collaborate...
5 years ago